193 related articles for article (PubMed ID: 10689610)
1. Quality of life and new antipsychotics in schizophrenia. Are patients better off?
Awad AG; Voruganti LN
Int J Soc Psychiatry; 1999; 45(4):268-75. PubMed ID: 10689610
[TBL] [Abstract][Full Text] [Related]
2. The new generation of antipsychotic drugs.
Tamminga CA; Lahti AC
Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():73-6. PubMed ID: 8803664
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia, VI: Treatments.
Lieberman JA; Stroup TS
Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
[No Abstract] [Full Text] [Related]
4. The value of atypical antipsychotics in the treatment of schizophrenia.
Jessen LM
Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
[No Abstract] [Full Text] [Related]
5. Ziprasidone: a new atypical antipsychotic.
Keck PE; McElroy SL; Arnold LM
Expert Opin Pharmacother; 2001 Jun; 2(6):1033-42. PubMed ID: 11585006
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
Keck PE; Strakowski SM; McElroy SL
J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
[TBL] [Abstract][Full Text] [Related]
7. Similarities and differences among antipsychotics.
Tamminga CA
J Clin Psychiatry; 2003; 64 Suppl 17():7-10. PubMed ID: 14680420
[TBL] [Abstract][Full Text] [Related]
8. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
Voruganti L; Cortese L; Owyeumi L; Kotteda V; Cernovsky Z; Zirul S; Awad A
Schizophr Res; 2002 Oct; 57(2-3):201-8. PubMed ID: 12223251
[TBL] [Abstract][Full Text] [Related]
9. Novel antipsychotic use in schizophrenia.
J Clin Psychiatry; 2000 Mar; 61(3):223-32. PubMed ID: 10841660
[No Abstract] [Full Text] [Related]
10. [New antipsychotic agents].
Olie JP; Ghaoui S; Bayle FJ
Encephale; 1999 Nov; 25 Spec No 3():52-60. PubMed ID: 10598295
[TBL] [Abstract][Full Text] [Related]
11. Use of atypical antipsychotics in mood disorders.
Weizman R; Weizman A
Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
[TBL] [Abstract][Full Text] [Related]
12. [Current pharmacotherapy of schizophrenia].
Bitter I
Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
[TBL] [Abstract][Full Text] [Related]
13. The role of atypical antipsychotics in the treatment of delirium.
Schwartz TL; Masand PS
Psychosomatics; 2002; 43(3):171-4. PubMed ID: 12075031
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
Kongsakon R; Leelahanaj T; Price N; Birinyi-Strachan L; Davey P
J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115
[TBL] [Abstract][Full Text] [Related]
15. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Hilger E; Kasper S
Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of schizophrenia.
Kane JM
Biol Psychiatry; 1999 Nov; 46(10):1396-408. PubMed ID: 10578454
[TBL] [Abstract][Full Text] [Related]
17. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
18. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
Swartz MS; Perkins DO; Stroup TS; Davis SM; Capuano G; Rosenheck RA; Reimherr F; McGee MF; Keefe RS; McEvoy JP; Hsiao JK; Lieberman JA;
Am J Psychiatry; 2007 Mar; 164(3):428-36. PubMed ID: 17329467
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Kapur S; Remington G
Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
[TBL] [Abstract][Full Text] [Related]
20. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
